Hoffmann Frank, Sotriffer Christoph, Evers Andreas, Xiong Guangming, Maser Edmund
Department of Pharmacology and Toxicology, Philipps University Marburg, Karl v Frisch Str 1, D-35033 Marburg, Germany.
J Biotechnol. 2007 Mar 30;129(1):131-9. doi: 10.1016/j.jbiotec.2006.11.024. Epub 2006 Dec 5.
3alpha-Hydroxysteroid dehydrogenase/carbonyl reductase (3alpha-HSD/CR) from Comamonas testosteroni belongs to the short chain dehydrogenase/reductase (SDR) protein superfamily and catalyzes the oxidoreduction of a variety of steroid substrates, including the steroid antibiotic fusidic acid. The enzyme also mediates the carbonyl reduction of non-steroidal aldehydes and ketones such as a novel insecticide. It is suggested that 3alpha-HSD/CR contributes to the bioremediation of natural and synthetic toxicants by C. testosteroni. Crystallization and structure analysis showed that 3alpha-HSD/CR is active as a dimer. Dimerization takes place via an interface axis which has exclusively been observed in homotetrameric SDRs but never in the structure of a homodimeric SDR. The formation of a tetramer is blocked in 3alpha-HSD/CR by the presence of a predominantly alpha-helical subdomain which is missing in all other SDRs of known structure. For example, 3alpha/20beta-HSD from Streptomyces hydrogenans exhibits two main subunit interfaces arranged about two non-crystallographic two-fold axes which are perpendicular to each other and referred to as P and Q. This mode of dimerization is, however, sterically impossible in 3alpha-HSD/CR because of a 28 amino acids insertion into the classical Rossmann-fold motif between strand betaE and helix alphaF. This insertion is masking helices alphaE and alphaF, thus preventing the formation of a four helix bundle and enables the dimerization via a P-axis interface. This type of dimerization in SDRs has never been observed in a crystal structure so far. The aim of this study was to investigate whether the lack of this predominantly alpha-helical subdomain keeps 3alpha-HSD/CR to be an active enzyme and whether, by an in silico approach, the formation of a homotetramer or even a novel oligomerization mode can be expected. Redesign of this interface was performed on the basis of site directed mutagenesis and according to other SDR structures by an approach combining "in silico" and "wet chemistry". Simulations of sterical and structural effects after different mutations, by applying a combination of homology modelling and molecular dynamic simulations, provided an effective tool for extensive mutagenesis studies and indicated the possibility of tetramer formation of truncated 3alpha-HSD/CR. In addition, despite lacking the extra loop domain, mutant 3alpha-HSD/CR was shown to be active towards a variety of standard substrates.
睾丸酮丛毛单胞菌的3α-羟基类固醇脱氢酶/羰基还原酶(3α-HSD/CR)属于短链脱氢酶/还原酶(SDR)蛋白超家族,可催化多种类固醇底物的氧化还原反应,包括类固醇抗生素夫西地酸。该酶还介导非甾体醛和酮(如新型杀虫剂)的羰基还原反应。有研究表明,3α-HSD/CR有助于睾丸酮丛毛单胞菌对天然和合成毒物的生物修复。结晶和结构分析表明,3α-HSD/CR以二聚体形式发挥活性。二聚化通过一个界面轴发生,这种界面轴仅在同四聚体SDR中观察到,而在同二聚体SDR的结构中从未见过。在3α-HSD/CR中,由于存在一个主要为α-螺旋的亚结构域,四聚体的形成受到阻碍,而在所有已知结构的其他SDR中都没有这个亚结构域。例如,氢化链霉菌的3α/20β-HSD表现出围绕两个相互垂直的非结晶二次轴排列的两个主要亚基界面,分别称为P和Q。然而,由于在βE链和αF螺旋之间的经典Rossmann折叠基序中插入了28个氨基酸,这种二聚化模式在3α-HSD/CR中在空间上是不可能的。这种插入掩盖了αE和αF螺旋,从而阻止了四螺旋束的形成,并使得通过P轴界面进行二聚化成为可能。到目前为止,在晶体结构中从未观察到SDR中的这种二聚化类型。本研究的目的是调查缺乏这个主要为α-螺旋的亚结构域是否会使3α-HSD/CR保持为一种活性酶,以及通过计算机模拟方法,是否可以预期形成同四聚体甚至一种新的寡聚化模式。基于定点诱变并根据其他SDR结构,通过结合“计算机模拟”和“湿化学”的方法对该界面进行了重新设计。通过应用同源建模和分子动力学模拟相结合的方法,对不同突变后的空间和结构效应进行模拟,为广泛的诱变研究提供了一种有效的工具,并表明了截短的3α-HSD/CR形成四聚体的可能性。此外,尽管缺少额外的环结构域,突变型3α-HSD/CR对多种标准底物仍表现出活性。